Impossible Foods and Beyond Meat have normalized the concept that 'meat' may no longer come from live animals. But some companies have taken that notion farther, growing meat directly from cells.

That next step for meat alternatives will apparently include fish.

Companies like Wild Type, BlueNalu, and Finless Foods wager that, in the age of Silicon Valley-masterminded plant-based burgers, there’s space and hunger for seafood grown in the lab.

“Our mission is basically to create the most delicious, the most sustainable, and cleanest fish and meat on the planet,” Wild Type co-founder Aryé Elfenbein told Cheddar. “We start with cells that come from fish. We grow them in nutrients ー kind of like a nutritious type of Gatorade ー and enable them to turn into things like muscle and fat, and then ultimately, the fish that we’re able to enjoy.”

The seafood market faces many of the same challenges that have propelled demand for meat alternatives, including health concerns, unease surrounding animal cruelty, and the environmental impact of farming.

Badly-managed fish farms can harm local ecology, while fishing in the wild can damage sea habitats and cause the underpopulation ー and potential decimation ー of a fish species.

Along with concerns about the ethics of meat consumption, the nascent industry is putting forward that with a rising global population, current supply sources, both farmed and wild fish, won’t be able to keep pace.

Fish consumption per capita has doubled over the past 50 years, according to research from the Joint Research Centre of the European Commission, a branch of the European Union.

Lab-grown fish could also avoid harmful contaminants that can be found in both wild and farmed fish, including mercury, toxins, parasites, and even tiny pieces of plastic caused by ocean pollution.

Wild Type, with $3.5 million fundraised to date according to Crunchbase, has focused its initial efforts on salmon. But the company’s real innovation, should it succeed, is to streamline a process for growing meat from cells that will produce a wide variety of products.

The lab-grown seafood industry is still small, but it has seen some signs of promise.

BlueNalu, a startup founded in 2017, has said that it is months away from producing a batch of lab-grown amberjack and mahi-mahi. The company recently raised $4.5 million and announced that it was expanding its facilities.

Meanwhile, Finless Foods, another lab-grown seafood competitor, is now producing bluefin tuna.

But there are key obstacles, namely cost, taste, and convincing people to eat fish that’s not from the ocean.

“This is basically meat that’s grown outside of an animal, which seems strange,” said Elfenbein. “It is quite different from the plant-based alternatives that you’re seeing.”

“We’re creating real meat, directly from the cells. And, in the end, it’s the same thing that you would get from an animal,” he added.

The company is hoping to emphasize its product’s versatility. At a June tasting dinner, it prepared myriad salmon dishes, including poke, rolls, and tartare, marking the first time that Wild Type produced a pound of product for one event.

But the salmon roll produced for that evening alone cost about $200 to make. Similarly, the Wall Street Journal reported that it costs Finless Fish about $4,000 to produce a pound of tuna.

“It is a bit more expensive than what we’re used to paying at our favorite sushi restaurants,” said the co-founder Justin Kolbeck. “Our goal is to really get the cost down to the point where people don’t have to pay a premium for the products that we’re making.”

Next steps will involve scaling up some of the technology involved and automating some of their processes. Kolbeck also emphasized that Wild Type plans to find ways to lower the cost of the nutrients required by its salmon's science.

“Our field is still at the kitchen-scale, where we’re making pounds of product now, which by the way is a big step forward,” said Kolbeck. “We’re testing the products, we’re getting input. We’re iterating. And I think what’s coming next for all us are some small-scale launches in partner restaurants.”

Share:
More In Business
Roomba maker iRobot files for bankruptcy protection; will be taken private under restructuring
Roomba maker iRobot has filed for Chapter 11 bankruptcy protection, but says that it doesn’t expect any disruptions to devices as the more than 30-year-old company is taken private under a restructuring process. iRobot said that it is being acquired by Picea through a court-supervised process. Picea is the company's primary contract manufacturer. The Bedford, Massachusetts-based anticipates completing the prepackaged chapter 11 process by February.
Serbia organized crime prosecutors charge minister, others in connection with Kushner-linked project
Serbia’s prosecutor for organized crime has charged a government minister and three others with abuse of position and falsifying of documents related to a luxury real estate project linked to U.S. President Donald Trump’s son-in-law Jared Kushner. The charges came on Monday. The investigation centers on a controversy over a a bombed-out military complex in central Belgrade that was a protected cultural heritage zone but that is facing redevelopment as a luxury compound by a company linked to Kushner. The $500 million proposal to build a high-rise hotel, offices and shops at the site has met fierce opposition from experts at home and abroad. Selakovic and others allegedly illegally lifted the protection status for the site by falsifying documentation.
Rare Dom Pérignon champagne from Charles and Diana’s wedding fails to sell during Denmark auction
A rare magnum of Dom Pérignon Vintage 1961 champagne that was specially produced for the 1981 wedding of Prince Charles and Lady Diana has failed to sell during an auction. Danish auction house Bruun Rasmussen handled the bidding Thursday. The auction's house website lists the bottle as not sold. It was expected to fetch up to around $93,000. It is one of 12 bottles made to celebrate the royal wedding. Little was revealed about the seller. The auction house says the bids did not receive the desired minimum price.
New York Times, after Trump post, says it won’t be deterred from writing about his health
The New York Times and President Donald Trump are fighting again. The news outlet said Wednesday it won't be deterred by Trump's “false and inflammatory language” from writing about the 79-year-old president's health. The Times has done a handful of stories on that topic recently, including an opinion column that said Trump is “starting to give President Joe Biden vibes.” In a Truth Social post, Trump said it might be treasonous for outlets like the Times to do “FAKE” reports about his health and "we should do something about it.” The Republican president already has a pending lawsuit against the newspaper for its past reports on his finances.
OpenAI names Slack CEO Dresser as first chief of revenue
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
Load More